Trevena Inc
$ 0.01
0.00%
24 Feb - close price
- Market Cap 9,500 USD
- Current Price $ 0.01
- High / Low $ 0.01 / 0.01
- Stock P/E N/A
- Book Value -27.27
- EPS -48.89
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.62 %
- ROE -10.15 %
- 52 Week High 1.80
- 52 Week Low 0.00
About
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of new drugs for patients affected by disorders of the central nervous system. The company is headquartered in Chesterbrook, Pennsylvania.
Analyst Target Price
$5.00
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
